Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR

Abstract

The prognosis of glioblastomas is still extremely poor and the discovery of novel molecular therapeutic targets can be important to optimize treatment strategies. Gene expression analyses comparing normal and neoplastic tissues have been used to identify genes associated with tumorigenesis and potential therapeutic targets. We have used this approach to identify differentially expressed genes between primary glioblastomas and non-neoplastic brain tissues. We selected 20 overexpressed genes related to cell cycle, cellular movement and growth, proliferation and cell-to-cell signaling and analyzed their expression levels by real time quantitative PCR in cDNA obtained from microdissected fresh tumor tissue from 20 patients with primary glioblastomas and from 10 samples of non-neoplastic white matter tissue. The gene expression levels were significantly higher in glioblastomas than in non-neoplastic white matter in 18 out of 20 genes analyzed: P < 0.00001 for CDKN2C, CKS2, EEF1A1, EMP3, PDPN, BNIP2, CA12, CD34, CDC42EP4, PPIE, SNAI2, GDF15 and MMP23b; and NFIA (P: 0.0001), GPS1 (P: 0.0003), LAMA1 (P: 0.002), STIM1 (P: 0.006), and TASP1 (P: 0.01). Five of these genes are located in contiguous loci at 1p31-36 and 2 at 17q24-25 and 8 of them encode surface membrane proteins. PDPN and CD34 protein expression were evaluated by immunohistochemistry and they showed concordance with the PCR results. The present results indicate the presence of 18 overexpressed genes in human primary glioblastomas that may play a significant role in the pathogenesis of these tumors and that deserve further functional investigation as attractive candidates for new therapeutic targets.

Relative quantitative expression of hypoxia-inducible factor-1α, −2α and −3α, and vascular endothelial growth factor A in laryngeal carcinoma

“…To determine the relative expression of each gene in the tumor, the 2-ΔΔCt method was applied (26 ΔΔCt , where ΔΔCt = ΔCt T -ΔCt N . An RQ of >2 was defined as overexpression, and an RQ of <0.5 was defined as underexpression of the gene, in agreement with previous studies (27,28).…”

ORAI1-Mediated Calcium Influx in Lactation and in Breast Cancer

“…STIM2 is amplified at the gene level in human Glioblastoma multiforme tumors (52) whereas STIM1 is overexpressed in primary glioblastomas compared with nonneoplastic tissue (53). STIM1 was initially proposed as a potential tumor suppressor in melanoma and rhabdoid tumor cell lines (54).…”

Prostate-derived factor—a novel inhibitor of drug-induced cell death in colon cancer cells

“…Increased PDF mRNA expression has been reported in glioblastomas (8). Immunohistochemical staining showed PDF overexpression in tumor compared with adjacent normal tissue in prostate (9,10), breast (11), colon (12), pancreatic (13), oral carcinomas (14), and highly aggressive metastatic melanoma (15).…”